Browse Category

Financial Forecasts News 15 December 2025

IREN Limited Stock (NASDAQ: IREN) News, Forecasts and Analysis for Dec. 15, 2025: Analysts Debate the Pullback After the Microsoft AI Deal

IREN Limited Stock (NASDAQ: IREN) News, Forecasts and Analysis for Dec. 15, 2025: Analysts Debate the Pullback After the Microsoft AI Deal

December 15, 2025 — IREN Limited (NASDAQ: IREN) is back in the spotlight as one of the most volatile “AI infrastructure” trades in U.S. markets. After a breathtaking surge earlier in 2025—driven by its pivot from bitcoin mining toward high-performance AI compute—IREN shares are now fighting through a sharp drawdown, with investors weighing dilution, capital intensity, and execution risk against a blockbuster hyperscaler contract. As of Dec. 15, 2025 at 17:29 UTC, IREN stock traded at $36.31, down 9.5% on the day, after swinging between $35.59 and $40.63 on roughly 30.3 million shares of volume. This article rounds up the
Boeing Stock (BA) Holds Near $204 as FAA 737 MAX Safety Plan, Delivery Outlook and Analyst Targets Shape 2026 Forecast

Boeing Stock (BA) Holds Near $204 as FAA 737 MAX Safety Plan, Delivery Outlook and Analyst Targets Shape 2026 Forecast

Dec. 15, 2025 — Boeing stock (NYSE: BA) traded essentially flat on Monday, hovering around $204 a share after moving through the low-$200s in the session, as investors balanced fresh aviation headlines with a growing focus on 2026 execution: deliveries, certification milestones, and cash flow. Boeing’s recent narrative has shifted from “what went wrong” to “what must go right next”—and today’s news cycle reinforced that reality. Regulatory actions tied to 737 MAX safety enhancements, the competitive year-end delivery sprint versus Airbus, and ongoing program risks in defense all sit alongside a more optimistic set of forecasts from management and Wall
AST SpaceMobile (ASTS) Stock News Today: BlueBird 6 Launch Delay, Analyst Forecasts, and Key Catalysts for Dec. 15, 2025

AST SpaceMobile (ASTS) Stock News Today: BlueBird 6 Launch Delay, Analyst Forecasts, and Key Catalysts for Dec. 15, 2025

Dec. 15, 2025 — AST SpaceMobile (NASDAQ: ASTS) is back in the spotlight as investors track a high-stakes launch event that’s become the defining near-term catalyst for the stock: BlueBird 6, the company’s first next-generation “direct-to-device” satellite designed to connect ordinary smartphones from space. On Monday, ASTS shares were volatile as traders digested fresh reports that the BlueBird 6 launch window has slipped from the original Dec. 15 target into late December, with multiple sources pointing to around Dec. 21. The Times of India+2Moneycontrol+2 What’s happening with AST SpaceMobile stock on Dec. 15, 2025 ASTS moved lower in Monday’s session,
Nutanix Stock (NTNX) Today: Sovereign Cloud Push, Pure Storage Partnership, and Analyst Forecasts After the Selloff

Nutanix Stock (NTNX) Today: Sovereign Cloud Push, Pure Storage Partnership, and Analyst Forecasts After the Selloff

December 15, 2025 — Nutanix, Inc. (NASDAQ: NTNX) is back in the spotlight as the enterprise cloud software company rolls out a fresh wave of platform updates aimed at one of the most politically and operationally charged themes in IT: sovereign clouds. The timing matters for investors because Nutanix stock has been digesting a sharp pullback since mid-November—and Monday’s headlines land right as the market tries to decide whether the move was an overreaction, a warning sign, or simply the cost of living in “high-expectations tech land.” As of Monday trading (Dec. 15), Nutanix stock was hovering around the $49
Astera Labs ALAB Stock News Today: NVLink Fusion Fallout, Fresh Forecasts, and What Wall Street Is Watching on Dec. 15, 2025

Astera Labs ALAB Stock News Today: NVLink Fusion Fallout, Fresh Forecasts, and What Wall Street Is Watching on Dec. 15, 2025

Astera Labs Inc. (Nasdaq: ALAB) is back in focus on Monday, Dec. 15, 2025, as investors weigh a string of December catalysts that have driven sharp swings in the AI infrastructure supply chain—especially around NVIDIA’s NVLink Fusion ecosystem and hyperscaler custom silicon roadmaps. As of 11:53 a.m. ET (16:53 UTC) on Dec. 15, ALAB traded around $150.02, up about 0.8% on the session, with an intraday range roughly between $143.32 and $152.07. The “why now” is a mix of: Why Astera Labs stock is moving in December 2025 ALAB’s December volatility traces back to a market question that keeps resurfacing:
Elon Musk Net Worth in 2025: Bloomberg Estimates $470 Billion as Tesla Robotaxi News and SpaceX IPO Talk Fuel Fresh Forecasts

Elon Musk Net Worth in 2025: Bloomberg Estimates $470 Billion as Tesla Robotaxi News and SpaceX IPO Talk Fuel Fresh Forecasts

Elon Musk’s net worth has once again become a daily headline—not because his paycheck changed, but because the market values of his companies did. As of December 15, 2025 (12:02 a.m. UTC), the Bloomberg Billionaires Index estimates Musk’s net worth at about $470 billion, with Tesla listed as his biggest asset. Bloomberg That figure is not a bank balance. It’s an estimate of the value of Musk’s stakes—mostly in Tesla, SpaceX, and his AI-and-social portfolio—minus liabilities, updated as stock prices move and private-company valuations get refreshed. Bloomberg explicitly describes its index as dynamic, updating figures every business day after U.S. trading closes, using the latest closing prices
UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group Incorporated (NYSE: UNH) is back in the spotlight as 2025 winds down—caught between “defensive” sector rotation, fresh legal headlines, and a fast-approaching earnings and guidance reset that could shape sentiment for 2026. As of 15:27 UTC on Monday, December 15, 2025, UNH stock traded at $337.51, down about 1.27% on the day, after moving between $337.07 and $344.84. Trading volume was about 1.75 million shares at that point in the session. That price action may look routine, but the story underneath isn’t. UnitedHealth is navigating a complicated mix of: Below is a comprehensive roundup of the most current
Amicus Therapeutics (FOLD) Stock News Today: DMX-200 Trial Milestone, 52-Week High Momentum, and Analyst Forecasts (Dec. 15, 2025)

Amicus Therapeutics (FOLD) Stock News Today: DMX-200 Trial Milestone, 52-Week High Momentum, and Analyst Forecasts (Dec. 15, 2025)

Amicus Therapeutics, Inc. (Nasdaq: FOLD) is back on investors’ radar as the rare-disease biotech extends a strong 2025 run—helped by a milestone quarter of GAAP profitability, expanding global launches for its Pompe franchise, and fresh news tied to a Phase 3 kidney-disease program it licensed earlier this year. On Monday, December 15, 2025, Amicus shares traded around $10.93 intraday after opening near $10.55, with the session range pushing into the low $11 area. Below is a detailed look at the latest Amicus Therapeutics stock news, what Wall Street is forecasting, and the key catalysts (and risks) investors are weighing as
Carvana Stock (CVNA) News Today: Argus Initiates “Buy” as S&P 500 Inclusion Nears — Latest Price Targets, Forecasts and Key Risks (Dec. 15, 2025)

Carvana Stock (CVNA) News Today: Argus Initiates “Buy” as S&P 500 Inclusion Nears — Latest Price Targets, Forecasts and Key Risks (Dec. 15, 2025)

Carvana Co. shares traded around $461 on Monday, extending a powerful run that has pushed the online used-car retailer back into the market spotlight just days before its scheduled S&P 500 entry. The fresh catalyst on Dec. 15, 2025: Argus Research initiated coverage with a “Buy” rating and a $500 price target, calling out Carvana’s competitive advantages versus traditional dealerships (selection, pricing, quality, and user experience). TradingView But as Carvana stock approaches (and in some sessions has flirted with) a $100+ billion valuation, the debate is getting sharper: is this the start of a new institutional chapter powered by index
Adtalem Global Education (ATGE) Stock Jumps After $750 Million Buyback Authorization: Latest News, Forecasts and 2026 Outlook (Dec. 15, 2025)

Adtalem Global Education (ATGE) Stock Jumps After $750 Million Buyback Authorization: Latest News, Forecasts and 2026 Outlook (Dec. 15, 2025)

CHICAGO — Adtalem Global Education Inc. (NYSE: ATGE) is back in the market spotlight on Monday, Dec. 15, 2025, after the healthcare-education provider announced it has finished a $150 million share repurchase program and its board has approved a new $750 million authorization running through December 2028. Adtalem Global Education The market liked the signal. ATGE was trading at $97.08 (up $4.20, roughly +4.5%) in afternoon trading around 14:46 UTC, after closing at $92.88 previously, according to consolidated market data. That “buyback headline” isn’t just a feel-good corporate gesture. For Adtalem, it lands in the middle of a multi-year story
AMD Stock Outlook (NASDAQ: AMD): Latest News, Analyst Forecasts, and Key Catalysts to Watch on December 15, 2025

AMD Stock Outlook (NASDAQ: AMD): Latest News, Analyst Forecasts, and Key Catalysts to Watch on December 15, 2025

Advanced Micro Devices (AMD) stock is attempting to steady itself on Monday, December 15, after last week’s sharp “AI trade” pullback put renewed focus on valuation, capital spending discipline, and Washington’s shifting rules for advanced chip exports. As of 14:43 UTC today (Dec. 15), AMD shares were at $213.13, up about 1.1% on the session, trading between $210.60 and $214.01 intraday. The backdrop matters: U.S. equity futures pointed higher into the open as investors braced for a data-heavy week that could reshape expectations for interest rates—an important driver for high-multiple tech and semiconductors. Reuters Key takeaways for AMD investors today
Tesla Stock (TSLA) Surges on Driverless Robotaxi Test Buzz as Board Pay Scrutiny and 2026 Forecasts Fuel the Debate (Dec. 15, 2025)

Tesla Stock (TSLA) Surges on Driverless Robotaxi Test Buzz as Board Pay Scrutiny and 2026 Forecasts Fuel the Debate (Dec. 15, 2025)

Tesla, Inc. stock (NASDAQ: TSLA) is back at the center of a familiar—and increasingly high-stakes—Wall Street argument: is Tesla primarily an electric-vehicle manufacturer facing demand headwinds, or an AI-and-autonomy platform nearing a step-change moment? On Monday, Dec. 15, Tesla shares jumped about 4.5% to $479.53 in early U.S. trading (as of 14:37 UTC / 9:37 a.m. ET), extending a volatile stretch where the stock’s price action has been tightly linked to new signals—real or perceived—about robotaxis and Full Self-Driving progress. Today’s catalyst mix is unusually broad: a reported milestone in Austin robotaxi testing, fresh governance scrutiny around director compensation, and
1 27 28 29 30 31 68

Stock Market Today

SGX share price dips at week’s end after record profit; what investors watch next

SGX share price dips at week’s end after record profit; what investors watch next

7 February 2026
Singapore Exchange shares closed 0.4% lower at S$17.57 on Friday, despite reporting record half-year results and a higher dividend earlier in the week. Broker targets diverged after the update, with Maybank and DBS raising targets while Citi stayed bearish. Investors are watching for signs of momentum from derivatives and equity-market reforms as the next session opens Monday.
South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Go toTop